Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2013
10/09/2013EP2646466A1 Means and methods for producing high affinity antibodies
10/09/2013EP2646463A1 Novel receptor-ligand interaction and uses thereof
10/09/2013EP2646053A2 Compositions and methods for treating amyloid plaque associated symptoms
10/09/2013EP2646050A1 Vaccine against influenza h5n1 viruses, medicament and treatment of h5n1 viral infections
10/09/2013EP2359854B1 Pharmaceutical compositions and methods useful for modulating angiogenesis
10/09/2013EP2261378B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class i membrane fusogenic envelope proteins
10/09/2013EP2101780B1 Methods of treating chronic inflammatory diseases using a gm-csf antagonist
10/09/2013CN103347898A Combination therapy including tumor associated antigen binding antibodies
10/09/2013CN103347897A Anti-mesothelin antibodies and immunoconjugates
10/09/2013CN103347896A Anti-CXCL13 antibodies and method of using same
10/09/2013CN103347895A Polypeptides that bind to human complement component C5
10/09/2013CN103347894A Anti-GD2 antibodies
10/09/2013CN103347540A Anti-alpha-v integrin antibody for the treatment of prostate cancer
10/09/2013CN103347538A Novel modulator and method of use
10/09/2013CN103347537A Anti-folate receptor alpha antibody glycoforms
10/09/2013CN103344758A Chemiluminescence enzyme immunoassay detection method and kit of sulfamethazine
10/09/2013CN103343109A Hybridoma cell strain, anti-salbutamol monoclonal antibody generated by hybridoma cell strain and application
10/09/2013CN103342752A Anti-human tissue factor single-chain antibody and preparation method thereof
10/09/2013CN103342751A Antibody neutralizers of human granulocyte macrophage colony stimulating factor
10/09/2013CN103342750A Apolipoprotein B nano antibody and coding sequence and application thereof
10/09/2013CN103342749A Triple egg yolk antibody against newcastle disease virus, avian influenza virus and infectious bronchitis virus
10/09/2013CN103342747A Artificial antigen and antibody for immunoassay of melamine residues and preparation method thereof
10/09/2013CN103342740A Blocking ELISA (Enzyme-Linked Immunosorbent Assay) method for detecting special avian HEV (Hepatitis E Virus) antibody
10/09/2013CN103342738A Fine epitope peptide capable of inducing cross-reactive antibodies among homologous proteins in human papilloma virus E6 protein
10/09/2013CN103342683A Quinocetone hapten as well as preparation method and application thereof
10/09/2013CN102112613B Genes, proteins and vectors for increaseing tolerance of plants and microbes to abiotic stresses and use thereof
10/09/2013CN102079783B Japanese blood fluke protein and application thereof
10/09/2013CN101942442B Novel beta-actin and rps21 promoters and uses thereof
10/09/2013CN101724072B Sequence and application thereof of anti-tumor monoclonal antibody
10/09/2013CN101437850B Anti-5T4 antibodies and uses thereof
10/09/2013CN101370526B Recombinant monovalent antibodies and methods for production thereof
10/08/2013US8552159 Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy
10/08/2013US8552157 c-Kit antibodies and uses thereof
10/08/2013US8552156 Anti-TIM-3 antibody
10/08/2013US8552155 Anti-Pyk2 antibodies
10/08/2013US8552154 Anti-PD-L1 antibodies and uses therefor
10/08/2013US8552148 TNF-α antagonists containing IGFBP5
10/08/2013US8551994 Affinity adsorbents for fibrinogen
10/08/2013US8551945 Methods and compositions for treating neuropathies
10/08/2013US8551790 MASP 2, a complement-fixing enzyme, and uses for it
10/08/2013US8551776 Estrogen receptors and methods of use
10/08/2013US8551715 Methods for identifying and isolating cells expressing a polypeptide
10/08/2013US8551699 PCA3, PCA3 genes, and methods of use
10/08/2013US8551493 Peptide with reduced dimer formation
10/08/2013US8551492 Vaccine peptide combinations against cat allergy
10/08/2013US8551490 Genetic products differentially expressed in tumors and use thereof
10/08/2013US8551488 Binding molecules for treatment and detection of cancer
10/08/2013US8551485 Anti-CD40 antibodies and methods of inhibiting proliferation of CD40 expressing cells
10/08/2013US8551484 Human antibodies against hepatitis C virus (HCV) and uses thereof
10/08/2013US8551483 Methods of treating viral infections by administering KIR2DL-binding antibodies
10/08/2013US8551482 Compositions and methods for increasing muscle growth
10/08/2013US8551481 Anti-cancer vaccine composition comprising an anti-CD223 antibody and kit comprising an anti-cancer vaccine and an anti-CD223 antibody
10/08/2013US8551480 Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity
10/08/2013US8551478 Anti-CD3 antibodies and methods of use thereof
10/08/2013CA2680222C Methods of treating ophthalmic diseases
10/08/2013CA2547459C Modulators of nik-siva complex formation for treating immune disorders
10/08/2013CA2515200C Galacturonosyltransferases, nucleic acids encoding same and uses therefor
10/08/2013CA2512647C Method for manufacturing recombinant polyclonal proteins
10/08/2013CA2501939C Novel immunogenic proteins of leptospira
10/08/2013CA2486307C Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
10/08/2013CA2453403C Methods of inhibiting amyloid toxicity
10/08/2013CA2349839C Ucp5
10/08/2013CA2238893C Il-13 receptor polypeptide
10/03/2013WO2013149259A1 Method for promoting lipolysis and oxidation in liver and adipose tissue using catestatin
10/03/2013WO2013149159A1 Anti-lgr5 antibodies and immunoconjugates
10/03/2013WO2013149111A2 Anti-tlr4 antibodies and uses thereof
10/03/2013WO2013149058A1 Monoclonal antibodies specific to human cav-1 and uses thereof
10/03/2013WO2013148877A1 Dr5 receptor agonist combinations
10/03/2013WO2013148695A1 Improved antitumor protocol
10/03/2013WO2013148373A1 Anti-hcmv idiotypic antibodies and uses thereof
10/03/2013WO2013148350A2 Anti-light antibody therapy for inflammatory bowel disease
10/03/2013WO2013148315A1 Diagnosis and treatments relating to her3 inhibitors
10/03/2013WO2013148296A1 Antibodies to bradykinin b1 receptor ligands
10/03/2013WO2013148284A1 Antibodies that bind to a pcsk9 cleavage site and methods of use
10/03/2013WO2013148263A1 Anti-emp2 therapy reduces cancer stem cells
10/03/2013WO2013148250A1 Tem-1 diagnostic antibodies
10/03/2013WO2013148248A1 Protease-regulated antibodies
10/03/2013WO2013148232A1 Methods of prognosing, diagnosing and treating idiopathic pulmonary fibrosis
10/03/2013WO2013147899A1 Osteoprotegerin derived composition and use thereof
10/03/2013WO2013147232A1 Bionanocapsule having antibody against surface protein of dendritic cell
10/03/2013WO2013147213A1 Anti-siglec15 antibody with modified cdr
10/03/2013WO2013147212A1 Novel anti-siglec15 antibody
10/03/2013WO2013147176A1 Pharmaceutical composition for treatment and/or prevention of gall bladder cancer
10/03/2013WO2013147169A1 Pharmaceutical composition for treatment and/or prevention of liver cancer
10/03/2013WO2013147076A1 FIBROSIS SUPPRESSION BY INHIBITING INTEGRIN α8β1 FUNCTION
10/03/2013WO2013146319A1 Diabetes-inducible bacterium
10/03/2013WO2013144567A1 Transgenic non-human vertebrate for the expression of class - switched, fully human, antibodies
10/03/2013WO2013144563A1 Treatment of acute inflammation in the respiratory tract
10/03/2013WO2013144266A1 Ang2-binding molecules
10/03/2013WO2013144240A1 Inhibition of interleukin- 8 and/or its receptor cxcrl in the treatment her2/her3 -overexpressing breast cancer
10/03/2013WO2013143806A1 Cell wall polymers of enterococcus faecalis and uses thereof
10/03/2013WO2013143504A1 Peptide and antibody libraries and uses thereof
10/03/2013WO2013095738A3 Monoclonal antibodies with altered affinities for human fcyri, fcyrllla, and c1q proteins
10/03/2013WO2013092743A3 Expression vector element combinations, novel production cell generation methods and their use for the recombinant production of polypeptides
10/03/2013WO2013078375A3 Administration of alpha4beta7 hetero-dimer-specific antibody
10/03/2013WO2012156975A8 COMBINATIONS OF ANTI ErbB ANTIBODIES FOR THE TREATMENT OF CANCER
10/03/2013WO2012047583A3 Antibodies binding human collagen ii
10/03/2013US20130263293 Animal models and therapeutic molecules
10/03/2013US20130261293 Gram-positive bacteria specific binding compounds
10/03/2013US20130261289 Optimized Fc Variants
1 ... 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 ... 1494